CP 55940

CAS : 83002-04-4

Ref. 3D-FD146910

Informations sur le produit

• Nom: CP 55940
• Synonymes: 5-(1,1-Dimethylheptyl)-2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]phenol, (-)-Cp 55940, 2-[(1S,2R,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol, 5-(1,1-dimethylheptyl)-2-[(1S,2R,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]phenol, Phenol, 5-(1,1-dimethylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-, (1α,2β,5α)-(-)-, phenol, 5-(1,1-dimethylheptyl)-2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-, phenol, 5-(1,1-dimethylheptyl)-2-[(1S,2R,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-
• CAS: 83002-04-4

Description

CP 55940 is a cannabinoid receptor agonist that inhibits acetylcholine release in the brain and has been shown to cause neuronal death. CP 55940 binds to the α7 nicotinic acetylcholine receptor, which is important for memory and learning. The binding of this drug causes an increase in guanine nucleotide-binding protein (G protein) activity by reducing the rate of GTP hydrolysis, leading to inhibition of adenylyl cyclase activity and subsequent decrease in cAMP levels. CP 55940 has significant up-regulation of toll-like receptors following exposure, which leads to an increased immune response. This drug can also cause bowel disease or side effects such as seizures and psychotic symptoms. CP 55940 can interact with other drugs, including cannabinoids that may lead to serious side effects.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 376.57 g/mol
• Formule: C₂₄H₄₀O₃
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C24H40O3/c1-4-5-6-7-14-24(2,3)19-11-13-21(23(27)16-19)22-17-20(26)12-10-18(22)9-8-15-25/h11,13,16,18,20,22,25-27H,4-10,12,14-15,17H2,1-3H3
• Code InChI: InChIKey=YNZFFALZMRAPHQ-UHFFFAOYSA-N
• SMILES: CCCCCCC(C)(C)c1ccc(C2CC(O)CCC2CCCO)c(O)c1